Compound 1661
Identifiers
- Common name: C4
- Canonical SMILES:
CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1
- IUPAC name:
chloropyramine
- InChi:
InChI=1S/C16H20ClN3/c1-19(2)11-12-20(16-5-3-4-10-18-16)13-14-6-8-15(17)9-7-14/h3-10H,11-13H2,1-2H3
- InChiKey:
ICKFFNBDFNZJSX-UHFFFAOYSA-N
External links
![]() 25295 |
![]() CHEMBL1194287 |
C4C |
DB08800 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
FAK / VEGFR3 | 6.24 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 289.13 g/mol | |||
HBA | 3 | |||
HBD | 0 | |||
HBA + HBD | 3 | |||
AlogP | 3.81 | |||
TPSA | 19.37 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
1.0000 | Chloropyramine | DB08800 | |
0.8861 | Tripelennamine | DB00792 | |
0.7609 | Mepyramine | DB06691 | |
0.5963 | Methapyrilene | DB04819 | |
0.5354 | Thonzylamine | DB11235 | |
0.5326 | N~3~-BENZYLPYRIDINE-2,3-DIAMINE | DB07281 | |
0.5222 | Histapyrrodine | DB13479 | |
0.5038 | 4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine | DB03916 | |
0.4964 | Esmirtazapine | DB06678 | |
0.4964 | Mirtazapine | DB00370 | |
0.4872 | 4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE | DB07809 | |
0.4762 | Antazoline | DB08799 | |
0.4750 | Azaperone | DB11376 | |
0.4713 | MSX-122 | DB12715 | |
0.4685 | Atevirdine | DB12264 |